# Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas

> **NCT00001237** · PHASE2 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 120 (—)

## Conditions studied

- Burkitt Lymphoma
- Lymphoma, Large-Cell, Diffuse
- Lymphoma, Small Noncleaved-Cell

## Interventions

- **DRUG:** granulocyte-macrophage colony stimulating factor (GM-CSF)

## Key facts

- **NCT ID:** NCT00001237
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1989-03
- **Primary completion:** —
- **Final completion:** 2000-04
- **Target enrollment:** 120 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001237, "Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00001237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*